Skip to main content

Alps Advisors Inc

SEC CIK
0001376113
Latest filing
Jul 29, 2026

CADL holding history

Candel Therapeutics, Inc. in every 13F filed by Alps Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CADL overviewAll 13F holders of CADLFull Q2 2026 holdings

Shares (Q2 2026)
74,363
Value
$765.9K
% of portfolio
<0.1%
Quarters held
5
Since Q2 2025
Holdings of CADL by Alps Advisors Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202674,363$765.9K<0.1%+14,734+24.7%AddedHolders
Q1 202659,629$292.2K<0.1%+14,550+32.3%AddedHolders
Q4 202545,079$254.7K<0.1%+18,801+71.5%AddedHolders
Q3 202526,278$134.0K<0.1%−767−2.8%ReducedHolders
Q2 202527,045$136.8K<0.1%+27,045NewHolders